.svg)
.jpeg)
Towards therapeutics for Autism Spectrum Disorder using Syngap1 heterozygous mouse model.
Here are our introductory comments:
Dr. James Clement gave a talk on Thursday, October 3rd titled Towards therapeutics for Autism Spectrum Disorder using Syngap1 heterozygous mouse model.
You may also like
64 - SYNGAP Study - Seizure Tracker
Invitae/Ciitizen & Praxis
63 - Targeting alternative splicing of SYNGAP1 using antisense oligonucleotides
Ben Prosser, PhD
University of Pennsylvania
23 - Cognition, behavior & clinical trials in SYNGAP1
Andrew Stanfield, PhD
Univ. of Edinburgh
